341 related articles for article (PubMed ID: 27267049)
21. Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.
Siva S; Callahan JW; Kron T; Chesson B; Barnett SA; Macmanus MP; Hicks RJ; Ball DL
Acta Oncol; 2015; 54(8):1105-12. PubMed ID: 25833329
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
Harder EM; Park HS; Chen ZJ; Decker RH
Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
[TBL] [Abstract][Full Text] [Related]
23. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of pre-therapy
Anthony GJ; Cunliffe A; Castillo R; Pham N; Guerrero T; Armato SG; Al-Hallaq HA
Med Phys; 2017 Jul; 44(7):3686-3694. PubMed ID: 28422299
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
27. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy.
Kim K; Lee J; Cho Y; Chung SY; Lee JJB; Lee CG; Cho J
Radiat Oncol J; 2017 Jun; 35(2):163-171. PubMed ID: 28712275
[TBL] [Abstract][Full Text] [Related]
29. [¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
Petit SF; van Elmpt WJ; Oberije CJ; Vegt E; Dingemans AM; Lambin P; Dekker AL; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):698-705. PubMed ID: 20884128
[TBL] [Abstract][Full Text] [Related]
30. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
31. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
[TBL] [Abstract][Full Text] [Related]
32. Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response.
Hart JP; McCurdy MR; Ezhil M; Wei W; Khan M; Luo D; Munden RF; Johnson VE; Guerrero TM
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):967-71. PubMed ID: 18495373
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
[TBL] [Abstract][Full Text] [Related]
34. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
35. [Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
Zhang Y; Yu YH; Yu JM; He W; Fu Z; Guo SF; Liu XJ; Cong CS
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):622-5. PubMed ID: 20021952
[TBL] [Abstract][Full Text] [Related]
36. An
Thor M; Lee C; Sun L; Patel P; Apte A; Grkovski M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Chaft JE; Rimner A; Gomez DR; Deasy JO; Shaverdian N
J Nucl Med; 2024 Apr; 65(4):520-526. PubMed ID: 38485270
[TBL] [Abstract][Full Text] [Related]
37. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
Chaudhuri AA; Tang C; Binkley MS; Jin M; Wynne JF; von Eyben R; Hara WY; Trakul N; Loo BW; Diehn M
Lung Cancer; 2015 Jul; 89(1):50-6. PubMed ID: 25997421
[TBL] [Abstract][Full Text] [Related]
39. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
[TBL] [Abstract][Full Text] [Related]
40. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.
Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y
Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
